Effect of mazindol on extracellular dopamine concentration in human brain measured by PET

[11] Gogerty JH(1996)A case of abuse of mazindol, administered as alternative to stimulants, resulting in recurrence of hallucination and delusion (kakuseizai daitai to shite mazindol wo rannyou shi gennkakumousou no sainenn wo teishita kakuseizaiseishinbyou no ichi rei) Neuroimaging 4 153-158

[12] Farde L(2000)Clinical evaluation of Mazindol in chronic schizophrenics J Cereb Blood Flow Metab 20 423-451

[13] Hall H(1985)A study of the problem of dependency of Mazindol –A clinical open survey Brain Res Bull 15 29-31

[14] Ehrin E(2001)Simplified reference tissue model for PET receptor studies Am J Psychiatry 158 1492-1499

[15] Sedvall G(1986)Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review A Clin Rep (Jpn) 20 2243-2278

[16] Innis RB(2010)Direct action of mazindol on guinea-pig ventromedial hypothalamic neurons: intracellular studies in slice preparation J Pharmacol Exp Ther 333 533-539

[17] Cunningham VJ(1988)Striatal dopamine transporters and cognitive functioning in healthy men and women J Pharmacol Exp Ther 245 199-210

[18] Delforge J(1985)Chronic toxicity test of mazindol in rats by oral 26-week administration Brain Res Bull 15 33-38

[19] Fujita M(2010)A comparative evaluation of the dopamine D2/3 agonist radiotracer [11C]( )- Neuroimaging 50 1402-1407

[20] Gjedde A(1999)-propyl-norapomorphine and antagonist [11C]raclopride to measure amphetamine-induced dopamine release in the human striatum Int J Neuropsychopharmacol 2 73-82

[11] Gogerty JH(1996)A case of abuse of mazindol, administered as alternative to stimulants, resulting in recurrence of hallucination and delusion (kakuseizai daitai to shite mazindol wo rannyou shi gennkakumousou no sainenn wo teishita kakuseizaiseishinbyou no ichi rei) Neuroimaging 4 153-158

[12] Farde L(2000)Clinical evaluation of Mazindol in chronic schizophrenics J Cereb Blood Flow Metab 20 423-451

[13] Hall H(1985)A study of the problem of dependency of Mazindol –A clinical open survey Brain Res Bull 15 29-31

[14] Ehrin E(2001)Simplified reference tissue model for PET receptor studies Am J Psychiatry 158 1492-1499

[15] Sedvall G(1986)Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review A Clin Rep (Jpn) 20 2243-2278

[16] Innis RB(2010)Direct action of mazindol on guinea-pig ventromedial hypothalamic neurons: intracellular studies in slice preparation J Pharmacol Exp Ther 333 533-539

[17] Cunningham VJ(1988)Striatal dopamine transporters and cognitive functioning in healthy men and women J Pharmacol Exp Ther 245 199-210

[18] Delforge J(1985)Chronic toxicity test of mazindol in rats by oral 26-week administration Brain Res Bull 15 33-38

[19] Fujita M(2010)A comparative evaluation of the dopamine D2/3 agonist radiotracer [11C]( )- Neuroimaging 50 1402-1407

[20] Gjedde A(1999)-propyl-norapomorphine and antagonist [11C]raclopride to measure amphetamine-induced dopamine release in the human striatum Int J Neuropsychopharmacol 2 73-82